Clinical trial
Study on TCM Syndrome Classification of Idiopathic Pulmonary Fibrosis Based on Metabolomics
NCT03711435 is registered in ClinicalTrials.gov with Xuzhou Traditional Chinese Medicine Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on TCM Syndrome Classification of Idiopathic Pulmonary Fibrosis Based on Metabolomics
- Lead sponsor
- Xuzhou Traditional Chinese Medicine Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 20, 2018
- Completion date
- February 5, 2020
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.